Table 2.
Overlap of marker expression in primary strains of human tracheal basal cells derived from different tracheas
| Frequency of positive cells (%) | Total markers | Overlap of markers between strains | ||||
|---|---|---|---|---|---|---|
| Strain 23 | Strain 38 | Validation strains a | Strain 23 b | Strain 38 c | Validation strains a | |
| <0.1 | 147 | 117 | 108 (73%) | 108 (92%) | ||
| 0.10-0.99 | 62 | 87 | 40 (65%) | 40 (46%) | ||
| 1.0-9.9 | 34 | 41 | 23 (68%) | 23 (53%) | ||
| 10.0-100 | 70 | 68 | 66 (94%) | 66 (97%) | ||
| 0.1-10.0 | 96 | 128 | 85 (89%) | 85 (66%) | ||
| 0.1-100 | 166 | 196 | 111 | 157 (95%) | 157 (80%) | 105 (95%) |
aValidation data were obtained using multiple strains of primary human tracheal basal cells that were not used in the initial high-throughput screens. bNumber and (percentage) of markers from strain 38 that are expressed (or not expressed, <0.1%) in the same indicated category of strain 23. cNumber and (percentage) of markers from strain 23 that are expressed (or not expressed, <0.1%) in the same indicated category of strain 38.